Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migalastat in Pediatric Fabry Disease
NCT03500094Phase 3Completed
- Sponsor
- Amicus Therapeutics
- Start
- Sep 2018
- Primary completion
- Feb 2021
- Modality
- Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of migalastat in Fabry disease (FD), sponsored by Amicus Therapeutics. Started Sep 2018; status: completed.
02
Drugs
migalastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT03500094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500094.